Infertility Tied to Poorer Cardiovascular Health in Women
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 11, 2024 -- A history of female infertility may serve as a marker for cardiovascular health (CVH) later in life, according to a study published online Jan. 5 in JAMA Network Open.
Amy R. Nichols, Ph.D., R.D., from Harvard University in Boston, and colleagues evaluated the association between infertility history with CVH at midlife (approximately age 50 years) among parous individuals. The analysis included 468 participants followed for approximately 18 years.
The researchers found that at midlife, the estimated overall American Heart Association Life’s Essential 8 score, a construct for ranking CVH in behavioral and biomedical domains, was 2.94 points lower, the biomedical score was 4.07 points lower, and the blood subdomain score was 5.98 points lower among those with versus without a history of infertility. There was also a trend toward a lower point estimate for the behavioral domain score (β = −1.81).
"This cohort study of parous individuals found evidence for an association between a history of infertility and lower overall and biomedical CVH scores," the authors write. "Our results provide additional weight to evidence suggesting inclusion of infertility history in assessing risk among female patients and demonstrate the importance of early identification and invocation of ongoing cardiovascular preventive strategies."
One author disclosed receiving personal fees from Modern Fertility for serving as a consultant on prenatal nutrition outside the submitted work.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.